Primary regulatory
GLUCOPHAGE (metformin hydrochloride) Label Information
FDA-approved prescribing label for Glucophage (metformin hydrochloride), indicated as an adjunct to diet and exercise to improve glycemic control in adults and children with type 2 diabetes mellitus.
U.S. Food and Drug AdministrationPublished 2017-01-01Accessed 2026-07-01
Registry record
Source metadata
- Publisher
- U.S. Food and Drug Administration
- Source type
- Primary regulatory
- Registry ID
fda-glucophage-metformin-label
Interpretation boundary
What this record can and cannot establish
Inclusion in the registry is not endorsement. The record supports only the claims that fit its design, population, date, and scope. Company, media, and community records can document that a claim was made without proving the claim itself.